SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-025997
Filing Date
2023-02-27
Accepted
2023-02-27 16:03:23
Documents
15
Period of Report
2023-02-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm237943d1_8k.htm   iXBRL 8-K 25529
2 EXHIBIT 99.1 tm237943d1_ex99-1.htm EX-99.1 13998
6 GRAPHIC tm237943d1_ex99-1img002.jpg GRAPHIC 4022
7 GRAPHIC tm237943d1_ex99-1img003.jpg GRAPHIC 3230
  Complete submission text file 0001104659-23-025997.txt   229062

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aptx-20230227.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aptx-20230227_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aptx-20230227_pre.xml EX-101.PRE 22593
9 EXTRACTED XBRL INSTANCE DOCUMENT tm237943d1_8k_htm.xml XML 3706
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38535 | Film No.: 23674680
SIC: 2834 Pharmaceutical Preparations